Osher Ester, Scapa Erez, Klausner Joseph, Greenman Yona, Tordjman Karen, Melhem Alla, Nachmany Ido, Sofer Yael, Geva Ravit, Blachar Arye, Stern Naftali, Santo Erwin
Endocr Pract. 2016 Jul;22(7):773-9. doi: 10.4158/EP151091.OR. Epub 2016 Feb 26.
To improve the preoperative assessment of pancreatic incidentalomas (PIs) by analysis of 1 index case and characterization of the published features of intrapancreatic accessory spleen (IPAS) compared to pancreatic neuroendocrine tumor (PNET).
A search of the literature using the online database MEDLINE.
In all, 46 cases of IPAS have been described to date: 17 were "presumed" as IPAS based on technetium-99m (Tc-99m) scanning, fine-needle aspiration (FNA) stain for CD8, or contrast-enhanced sonography; 29 were misdiagnosed as PNET and underwent surgery. The pancreatic lesions were 1) mostly solitary; 2) solid on imaging; 3) well defined; 4) located predominantly at the pancreatic tail; 5) not exceeding 3 cm in the largest diameter; 5) all detected in adults (22-81 years); 6) not related to sex. In subjects referred for surgery, standard imaging studies/imaging protocols did not differentiate between IPAS and PNET. FNA was performed in 5/46 cases, all of which were false-positive for PNET. Immunohistochemical staining for T-cells on FNA material and specific imaging features (characteristic arciform splenic enhancement pattern on dynamic computed tomography [CT]; nuclear scintigraphies with radioisotope specifically trapped by splenic tissue [Tc-99m]) or contrast-enhanced sonography offered valuable clues. Still, distal pancreatectomy and splenectomy was carried out in 72%, and the rest had distal pancreatectomies.
IPAS should be considered before surgery in patients with PIs. A new practical algorithm is presented for better preoperative evaluation of such lesions; it combines the recognition of early indicators and sequential consideration of cytologic and imaging features to decrease the hazards of unnecessary major surgery.
CT = computed tomography EUS = endoscopic ultrasound FNA = fine-needle aspiration HDRBC = heat-damaged red blood cells IPAS = intrapancreatic accessory spleen MRI = magnetic resonance tomography NF-PNET = nonfunctioning pancreatic neuroendocrine tumor PET = positron emission tomography PNET = pancreatic neuroendocrine tumor PI = pancreatic incidentalomas SPIO = superparamagnetic iron oxide Tc-99m = technetium-99m.
通过分析1例索引病例,并对比胰腺神经内分泌肿瘤(PNET),对胰腺偶发瘤(PI)的胰腺内副脾(IPAS)已发表特征进行描述,以改进PI的术前评估。
使用在线数据库MEDLINE检索文献。
迄今为止,共描述了46例IPAS病例:17例基于99m锝(Tc-99m)扫描、细针穿刺(FNA)CD8染色或超声造影被“推测”为IPAS;29例被误诊为PNET并接受了手术。胰腺病变具有以下特点:1)大多为单发;2)影像学表现为实性;3)边界清晰;4)主要位于胰尾;5)最大直径不超过3 cm;6)均在成人(22 - 81岁)中发现;7)与性别无关。在接受手术的患者中,标准影像学检查/成像方案无法区分IPAS和PNET。46例中有5例进行了FNA,所有结果对PNET均为假阳性。FNA材料的T细胞免疫组化染色以及特定影像学特征(动态计算机断层扫描[CT]上特征性的弧形脾脏强化模式;放射性核素被脾脏组织特异性捕获的核闪烁扫描[Tc-99m])或超声造影提供了有价值的线索。尽管如此,72%的患者接受了胰体尾切除术和脾切除术,其余患者接受了胰体尾切除术。
对于PI患者,术前应考虑IPAS。本文提出了一种新的实用算法,用于对此类病变进行更好的术前评估;该算法结合了早期指标的识别以及对细胞学和影像学特征的序贯考虑,以降低不必要的大手术风险。
CT = 计算机断层扫描;EUS = 内镜超声;FNA = 细针穿刺;HDRBC = 热损伤红细胞;IPAS = 胰腺内副脾;MRI = 磁共振断层扫描;NF-PNET = 无功能性胰腺神经内分泌肿瘤;PET = 正电子发射断层扫描;PNET = 胰腺神经内分泌肿瘤;PI = 胰腺偶发瘤;SPIO = 超顺磁性氧化铁;Tc-99m = 99m锝